ZANACODAR COMBI

This brand name is authorized in Poland

Active ingredients

The drug ZANACODAR COMBI contains a combination of these active pharmaceutical ingredients (APIs):

1 Telmisartan UNII U5SYW473RQ - TELMISARTAN

Telmisartan is an orally active and specific angiotensin II receptor (type AT1) antagonist. Telmisartan selectively binds the AT1 receptor. The binding is long-lasting. Read about Telmisartan

2 Hydrochlorothiazide UNII 0J48LPH2TH - HYDROCHLOROTHIAZIDE

Hydrochlorothiazide is a diuretic with antihypertensive properties. It acts by inhibiting the renal tubular re-absorption of sodium and chloride ions, which are excreted with an accompanying volume of water. Potassium excretion is also promoted. Read about Hydrochlorothiazide

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
C09DA07	Telmisartan and diuretics	C Cardiovascular system → C09 Agents acting on the renin-angiotensin system → C09D Angiotensin II antagonists, combinations → C09DA Angiotensin II antagonists and diuretics
Discover more medicines within C09DA07

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100346557, 100346563, 100346570